Targeting Cancer Treatment with Angiotensin II
Author Information
Author(s): J.H. Anderson, N. Willmott, R. Bessent, W.J. Angerson, D.J. Kerr, C.S. McArdle
Primary Institution: The Royal Infirmary, Glasgow
Hypothesis
Can angiotensin II improve the targeting of microspheres to renal tumors?
Conclusion
Angiotensin II infusion significantly enhances the targeting of drug-loaded microspheres to renal tumors.
Supporting Evidence
- Angiotensin II increased microsphere distribution to tumor by a factor of four.
- Blood flow to the tumor increased significantly after angiotensin II infusion.
- Microsphere targeting was assessed using multiple imaging techniques.
Takeaway
This study shows that a special medicine can help deliver cancer treatment directly to a tumor in the kidney, making it work better.
Methodology
The study involved a patient receiving an angiotensin II infusion during renal angiography, followed by nephrectomy, with blood flow measurements and imaging to assess microsphere distribution.
Limitations
The study was conducted on a single patient, limiting the generalizability of the results.
Participant Demographics
One 57-year-old male patient with renal carcinoma.
Want to read the original?
Access the complete publication on the publisher's website